Trial record 37 of 88 for: "Neuromuscular Disease" | "Norepinephrine"
A Study Of Milnacipran In Patients With Fibromyalgia: Effects On 24 Hour Ambulatory Blood Pressure Monitoring
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00618956|
Recruitment Status : Completed
First Posted : February 20, 2008
Results First Posted : September 3, 2009
Last Update Posted : November 20, 2009
Cypress Bioscience, Inc.
Information provided by:
|Study Design||Allocation: Randomized; Intervention Model: Parallel Assignment; Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor); Primary Purpose: Treatment|
Drug: Milnacipran hydrochloride
|Recruitment Details||Recruitment period was from October 15, 2007 to April 16, 2008 at 38 centers in the US.|
|Pre-assignment Details||Following 1-to-4 week washout/single-blind placebo lead-in period, patients were randomized (2:1) to one of the treatment groups, milnacipran or placebo, respectively; and orally treated with study medication for 7-week, double-blind treatment period (Visit 2 to 6), followed by a 2-week single-blind placebo discontinuation period (Visit 6 to 8).|